AAAAAA
Results:
1-20
|
Results: 20
Authors:
HEGUY A
CAI P
MEYN P
HOUCK D
RUSSO S
MICHITSCH R
PEARCE C
KATZ B
BRINGMANN G
FEINEIS D
TAYLOR DL
TYMS AS
Citation: A. Heguy et al., ISOLATION AND CHARACTERIZATION OF THE FUNGAL METABOLITE 3-O-METHYLVIRIDICATIN AS AN INHIBITOR OF TUMOR-NECROSIS-FACTOR ALPHA-INDUCED HUMAN-IMMUNODEFICIENCY-VIRUS REPLICATION, Antiviral chemistry & chemotherapy, 9(2), 1998, pp. 149-155
Authors:
TAYLOR DL
AHMED PS
BRENNAN TM
BRIDGES CG
TYMS AS
VANDORSSELAER V
TARNUS C
HORNSPERGER JM
SCHIRLIN D
Citation: Dl. Taylor et al., ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS ACTIVITY, BIOAVAILABILITY AND DRUG-RESISTANCE PROFILE OF THE NOVEL PROTEINASE-INHIBITOR MDL-74,695, Antiviral chemistry & chemotherapy, 8(3), 1997, pp. 205-214
Authors:
NAVE JF
CASARA PJ
TAYLOR DL
TYMS AS
KENNY M
HALAZY S
Citation: Jf. Nave et al., SYNTHESIS, ENZYMATIC PHOSPHORYLATION AND ANTIVIRAL ACTIVITY OF ACYCLIC DIENYL PHOSPHONATE DERIVATIVES OF GUANINE, Bioorganic & medicinal chemistry letters, 6(2), 1996, pp. 179-184
Authors:
TAYLOR DL
AHMED SP
BRENNAN TM
NAVE JF
CASARA P
TYMS AS
Citation: Dl. Taylor et al., ANTI-HIV ACTIVITY OF MDL-74968, A NOVEL ACYCLONUCLEOTIDE DERIVATIVE OF GUANINE - DRUG-RESISTANCE AND DRUG-COMBINATION EFFECTS IN-VITRO, Antiviral chemistry & chemotherapy, 7(5), 1996, pp. 253-260
Authors:
BRIDGES CG
TAYLOR DL
AHMED PS
BRENNAN TM
HORNSPERGER JM
NAVE JF
CASARA P
TYMS AS
Citation: Cg. Bridges et al., MDL-74,968, A NEW ACYCLONUCLEOTIDE ANALOG - ACTIVITY AGAINST HUMAN-IMMUNODEFICIENCY-VIRUS IN-VITRO AND IN THE HU-PBL-SCID.BEIGE MOUSE MODELOF INFECTION, Antimicrobial agents and chemotherapy, 40(5), 1996, pp. 1072-1077
Authors:
CASARA PJ
ALTENBURGER JM
TAYLOR DL
TYMS AS
KENNY M
NAVE JF
Citation: Pj. Casara et al., SYNTHESIS AND ANTIVIRAL ACTIVITY OF RIGID ACYCLONUCLEOTIDE ANALOGS, Bioorganic & medicinal chemistry letters, 5(12), 1995, pp. 1275-1280
Authors:
BRIDGES CG
TAYLOR DL
KANG MS
BRENNAN TM
TYMS AS
Citation: Cg. Bridges et al., TREATMENT WITH THE ALPHA-GLUCOSIDASE-1 INHIBITOR 6-O-BUTANOYL CASTANOSPERMINE REDUCES THE DETECTION OF LFA-1 (CD18 CD11A) BY MONOCLONAL-ANTIBODIES/, Glycobiology, 5(2), 1995, pp. 243-247
Authors:
BRIDGES CG
AHMED SP
KANG MS
NASH RJ
PORTER EA
TYMS AS
Citation: Cg. Bridges et al., THE EFFECT OF ORAL TREATMENT WITH 6-O-BUTANOYL CASTANOSPERMINE (MDL-28,574) IN THE MURINE ZOSTERIFORM MODEL OF HSV-1 INFECTION, Glycobiology, 5(2), 1995, pp. 249-253
Authors:
SNYDER RD
BRENNAN T
TAYLOR DL
TYMS AS
Citation: Rd. Snyder et al., BASIS OF RELATIVE INSENSITIVITY OF HIV-INFECTED JM CELLS TO AZT, Antiviral chemistry & chemotherapy, 6(5), 1995, pp. 307-311
Authors:
TAYLOR DL
BRENNAN TM
BRIDGES CG
KANG MS
TYMS AS
Citation: Dl. Taylor et al., SYNERGISTIC INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN-VITRO BY 6-0-BUTANOYLCASTANOSPERMINE (MDL-28-574) IN COMBINATION WITH INHIBITORS OF THE VIRUS-ENCODED REVERSE-TRANSCRIPTASE AND PROTEINASE, Antiviral chemistry & chemotherapy, 6(3), 1995, pp. 143-152
Authors:
AHMED SP
CARDIN AD
BRIDGES CG
JACKSON RL
MULLINS MJ
TYMS AS
Citation: Sp. Ahmed et al., POTENT INHIBITION OF HERPES-SIMPLEX-VIRUS BY MDL-101028, A NOVEL BIPHENYL DISULFONIC ACID UREA COPOLYMER, Antiviral chemistry & chemotherapy, 6(1), 1995, pp. 34-42
Authors:
TAYLOR DL
BRENNAN TM
BRIDGES CG
MULLINS MJ
TYMS AS
JACKSON R
CARDIN AD
Citation: Dl. Taylor et al., POTENT INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS BY MDL-101028, A NOVEL SULFONIC-ACID POLYMER, Antiviral research, 28(2), 1995, pp. 159-173
Authors:
BRIDGES CG
AHMED SP
SUNKARA PS
MCCARTHY JR
TYMS AS
Citation: Cg. Bridges et al., THE RIBONUCLEOTIDE REDUCTASE INHIBITOR (E)-2'-FLUOROMETHYLENE-2'-DEOXYCYTIDINE (MDL-101,731) - A POTENTIAL TOPICAL THERAPY FOR HERPES-SIMPLEX VIRUS-INFECTION, Antiviral research, 27(4), 1995, pp. 325-334
Authors:
BRENNAN TM
TAYLOR DL
BRIDGES CG
LEYDA JP
TYMS AS
Citation: Tm. Brennan et al., THE INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN-VITRO BY A NONNUCLEOSIDE REVERSE-TRANSCRIPTASE INHIBITOR MKC-442, ALONE AND IN COMBINATION WITH OTHER ANTI-HIV COMPOUNDS, Antiviral research, 26(2), 1995, pp. 173-187
Authors:
AHMED SP
NASH RJ
BRIDGES CG
TAYLOR DL
KANG MS
PORTER EA
TYMS AS
Citation: Sp. Ahmed et al., ANTIVIRAL ACTIVITY AND METABOLISM OF THE CASTANOSPERMINE DERIVATIVE MDL-28,574, IN CELLS INFECTED WITH HERPES-SIMPLEX VIRUS TYPE-2, Biochemical and biophysical research communications, 208(1), 1995, pp. 267-273
Authors:
SCHIRLIN D
VANDORSSELAER V
TARNUS C
TAYLOR DL
TYMS AS
BALTZER S
WEBER F
REMY JM
BRENNAN T
FARR R
JANOWICK D
Citation: D. Schirlin et al., BENEFICIAL REPLACEMENT OF THE P-1 PHENYLALANINE SIDE-CHAIN IN HIV-1 PROTEASE INHIBITORS OF THE DIFLUOROSTATONE TYPE, Bioorganic & medicinal chemistry letters, 4(2), 1994, pp. 241-246
Authors:
VANDORSSELAER V
SCHIRLIN D
TARNUS C
TAYLOR DL
TYMS AS
WEBER F
BALTZER S
REMY JM
BRENNAN T
JANOWICK D
Citation: V. Vandorsselaer et al., INCREASED ANTIVIRAL ACTIVITY OF HIV PROTEASE INHIBITORS OF THE DIFLUOROSTATONE TYPE BEARING (R)-VALINOL DERIVATIVES AS NOVEL C-TERMINI, Bioorganic & medicinal chemistry letters, 4(10), 1994, pp. 1213-1218
Authors:
BRIDGES CG
BRENNAN TM
TAYLOR DL
MCPHERSON M
TYMS AS
Citation: Cg. Bridges et al., THE PREVENTION OF CELL-ADHESION AND THE CELL-TO-CELL SPREAD OF HIV-1 IN-VITRO BY THE ALPHA-GLUCOSIDASE-1 INHIBITOR, 6-O-BUTANOYL CASTANOSPERMINE (MDL-28574), Antiviral research, 25(2), 1994, pp. 169-175
Authors:
TAYLOR DL
KANG MS
BRENNAN TM
BRIDGES CG
SUNKARA PS
TYMS AS
Citation: Dl. Taylor et al., INHIBITION OF ALPHA-GLUCOSIDASE-I OF THE GLYCOPROTEIN-PROCESSING ENZYMES BY 6-O-BUTANOYL CASTANOSPERMINE (MDL-28,574) AND ITS CONSEQUENCES IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED T-CELLS, Antimicrobial agents and chemotherapy, 38(8), 1994, pp. 1780-1787
Authors:
SCHROEDER K
BOWLIN TL
BRIDGES G
TAYLOR D
TYMS AS
CARDIN AD
Citation: K. Schroeder et al., SPECIFIC INTERACTION OF 4,4'-DIISOTHIOCYANATOSTILBENE-2,2'-DISULFONICACID WITH HUMAN CELLULAR CD4, Cellular immunology, 159(1), 1994, pp. 103-110
Risultati:
1-20
|